Abstract
Background: Osteonecrosis of the femoral head (ONFH) is a progressive disease where oxidative stress and chondrocyte apoptosis contribute to cartilage degeneration and postoperative complications. Identifying reliable biochemical markers is essential for prognosis after hip resurfacing arthroplasty (HRA).
Methods: A retrospective analysis was conducted in 134 ONFH patients (ARCO stage II–III) treated with HRA. Serum oxidative stress markers—reactive oxygen species (ROS), superoxide dismutase (SOD), and malondialdehyde (MDA)—were measured preoperatively and at serial postoperative timepoints. Chondrocyte apoptosis rates were assessed by flow cytometry. Pain and functional recovery were evaluated using VAS and Harris hip scores. Correlation, univariate, and Cox regression analyses were applied to determine associations with postoperative outcomes.
Results: Patients with high oxidative stress had significantly increased ROS and MDA levels, reduced SOD activity, and elevated chondrocyte apoptosis (P<0.05). These patients showed delayed functional recovery and higher complication rates. Strong correlations were observed between oxidative markers and apoptosis (ROS: r=0.912; MDA: r=0.901; SOD: r=−0.875). Cox regression identified ROS, MDA, reduced SOD, and apoptosis as independent risk factors for postoperative failure (HR range: 1.06–1.49, all P<0.05).
Conclusion: Serum oxidative stress markers and chondrocyte apoptosis rates are closely linked to joint recovery and complications after HRA in ONFH patients. These biochemical indicators may serve as prognostic biomarkers, supporting early identification of high-risk individuals and guiding personalized postoperative interventions.
Keywords
Array
Array
Array
Array
Array
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.